75 results on '"Fredman, Gabrielle"'
Search Results
2. Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice
3. Resolvin D2 limits atherosclerosis progression via myeloid cell‐GPR18
4. Resolvin D2–G-Protein Coupled Receptor 18 Enhances Bone Marrow Function and Limits Steatosis and Hepatic Collagen Accumulation in Aging
5. Insulin sensitization by hepatic FoxO deletion is insufficient to lower atherosclerosis in mice
6. Specialized pro‐resolving mediators enhance the clearance of dead cells
7. Sex differences in the effects of high fat diet on underlying neuropathology in a mouse model of VCID
8. Abstract 456: Myeloid RvD2-GPR18 Signaling Axis Limits Plaque Necrosis
9. Resolvin D2-GPR18 Signaling on Myeloid Cells Limits Plaque Necrosis
10. Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice
11. The Resolvin D2-GPR18 Axis Enhances Bone Marrow Function and Limits Hepatic Fibrosis in Aging
12. IL-18R-mediated HSC quiescence and MLKL-dependent cell death limit hematopoiesis during infection-induced shock
13. What Makes a Great Mentor: Interviews With Recipients of the ATVB Mentor of Women Award
14. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect
15. Radiation-Induced Macrophage Senescence Impairs Resolution Programs and Drives Cardiovascular Inflammation
16. Macrophages Govern the Progression and Termination of Inflammation in Atherosclerosis and Metabolic Diseases
17. Endothelial SOCS3 maintains homeostasis and promotes survival in endotoxemic mice
18. Pro-Resolving Ligands Orchestrate Phagocytosis
19. Sub-lethal radiation-induced senescence impairs resolution programs and drives cardiovascular inflammation
20. Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis
21. Resolvin D1 Enhances Necroptotic Cell Clearance Through Promoting Macrophage Fatty Acid Oxidation and Oxidative Phosphorylation
22. Specialized Pro-Resolving Lipid Derived Fatty Acid Mediators: Wiring the Circuitry of Effector Immune Homeostasis
23. Endothelial SOCS3 maintains homeostasis and promotes survival in endotoxemic mice
24. Devouring atherosclerotic plaques
25. Next-Gen Inflammation Resolution
26. Resolvin D1 promotes efferocytosis in aging by limiting senescent cell‐induced MerTK cleavage
27. Resolvin D1 promotes the targeting and clearance of necroptotic cells
28. Resolving atherosclerosis and Alzheimer disease
29. Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
30. Resolving inflammation and pain of sickle cell
31. DELineating resolution of inflammation
32. Abstract 002: Resolvin D1 Limits Senescent Cells in Atherosclerosis
33. Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
34. Specialized pro-resolving mediators in cardiovascular diseases
35. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis
36. Pro-resolution therapeutics for cardiovascular diseases
37. Boosting Inflammation Resolution in Atherosclerosis
38. Fine-tuning inflammation-resolution programs
39. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis
40. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
41. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation
42. Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis
43. Platelets
44. Abstract 415: Resolvin D1 Limits 5-lipoxygenase Nuclear Localization and Leukotriene B4 Synthesis by Inhibiting a Calcium-activated Kinase Pathway
45. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
46. Annexin A1–containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair
47. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B 4 synthesis by inhibiting a calcium-activated kinase pathway
48. Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
49. Common Therapeutic Targets in Cardiometabolic Disease
50. Annexin A1 released from epithelial extracellular vesicles and synthetic nanoparticles promotes wound repair (488.5)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.